Follow on Google News News By Tag Industry News News By Place Country(s) Industry News
Follow on Google News | Biopharmaceutical Contract Manufacturing: Key Growth AreasBy: Roots Analysis Shefali Asija, the principal analyst, said, “Owing to a strong pipeline and complexity associated with manufacturing, the biopharmaceutical industry has garnered the interest of a lot of CMOs. Niche sectors such as ADCs and bispecific antibodies characterised by untapped potential and huge growth prospects serve as the potential demand segments for CMOs; rapidly emerging market for biosimilars is yet another encouraging factor.” The report examines insights gathered from interviews of important stakeholders such as FUJIFILM Diosynth Biotechnologies, Goodwin Biotechnology, Rentschler, Novasep, Piramal Pharma Solutions and Catalent. Asija further stated, “Majority of our work is supported by detailed research. For the purposes of this report, we studied close to 110 collaborations which have taken place over the past few years. The success of the market lies in the intensifying framework of investment activity and technological advancements.” Key topics covered in the latest report are: - Analysis of contract manufacturers involved in biopharmaceutical manufacturing - Future market evolution - Profiles of leading companies in developed and emerging regions - Focus on niche segments including ADCs, bispecific antibodies and gene therapy - Outsourcing outlook for biosimilars - Recent deals and partnerships - Investment programs Who will benefit from this report? This research is targeted towards biopharma companies and CMOs working in the field of biopharmaceuticals. In particular, you will benefit if you are an: - Investor - Contract Manufacturer - R&D Manager - Business Intelligence / Scientific Analyst - Licensing / Portfolio Manager - Strategy Manager For additional details and/or to request sample pages, please visit http://www.rootsanalysis.com/ About Roots Analysis Roots Analysis is a specialist market research company, sharing fresh and independent perspectives in the bio-pharmaceutical industry. The in-depth research, analysis and insights are driven by an experienced leadership team which has gained many years of significant experience in this sector. End
Account Email Address Account Phone Number Disclaimer Report Abuse
|
|